Nasal Insulin Won’t Stop Juvenile Diabetes
Juvenile or Type 1 diabetes is serious and life long. Parents, researchers and medical professionals have been looking for ways to limit or overcome the disease for a long time.
Though there is medication available to control Type 1 diabetes, there is no cure at this time, and no way to reverse the symptoms and side effects more than just somewhat doing so.
Researchers have been looking at nasal insulin for a while as one means of avoiding or controlling Type 1 diabetes. Recently, however, there was a study done with nasal insulin and the results were not as promising as researchers had hoped.
The study included 264 children who tested positive for two or more antibodies associated with diabetes. Blood samples to test for the antibodies were taken 3 to 6 months apart. In the study, 137 children were given nasal insulin for nearly two years and 127 children were given a placebo.
In the group given the placebo, 53 children eventually developed diabetes. In the group given the nasal insulin, 56 children eventually developed diabetes. These results show that the nasal insulin did not delay or offset the development of diabetes in children with genetic risk of the disease, even though the nasal insulin began to be administered very soon after the antibodies pointing to risk and eventual development of Type 1 diabetes were found to be present in these children.
Prerequisites for developing Type 1 diabetes are usually present very early in a child’s life and the development of Type 1 diabetes usually takes place before age 13. More research will be done to determine whether or not a different type of nasal insulin will at least control Type 1 diabetes.
